Pre-Clinical Characterization of Dacomitinib (PF-00299804), an Irreversible Pan-ErbB Inhibitor, Combined with Ionizing Radiation for Head and Neck Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

Pre-Clinical Characterization of Dacomitinib (PF-00299804), an Irreversible Pan-ErbB Inhibitor, Combined with Ionizing Radiation for Head and Neck Squamous Cell Carcinoma

Published:2014-05-22 Issue:5 Volume:9 Page:e98557
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Williams Justin P.,Kim Inki,Ito Emma,Shi Wei,Yue Shijun,Siu Lillian L.,Waldron John,O'Sullivan Brian,Yip Kenneth W.,Liu Fei-Fei

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference56 articles.

1. The molecular biology of head and neck cancer;CR Leemans;Nat Rev Cancer,2011

2. Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck;DM Shin;Head Neck,2013

3. Strojan P, Corry J, Eisbruch A, Vermorken JB, Mendenhall WM, et al. (2013) Recurrent and second primary squamous cell carcinoma of the head and neck: When and how to reirradiate. Head Neck.

4. Epidermal growth factor receptor biology in head and neck cancer;S Kalyankrishna;J Clin Oncol,2006

5. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells;Q Zhang;Cancer Res,2004

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Inhibitors of EGFR: Structure, Biology, Biomarkers, and Clinical Applications;Cells;2023-12-25

2. Emerging tyrosine kinase inhibitors for head and neck cancer;Expert Opinion on Emerging Drugs;2022-07-03

3. Dacomitinib and gedatolisib in combination with fractionated radiation in head and neck cancer;Clinical and Translational Radiation Oncology;2021-01

4. Is there a role for dacomitinib, a second-generation irreversible inhibitor of the epidermal-growth factor receptor tyrosine kinase, in advanced non-small cell lung cancer?;Expert Opinion on Pharmacotherapy;2020-04-15

5. How Different Substitution Positions of F, Cl Atoms in Benzene Ring of 5-Methylpyrimidine Pyridine Derivatives Affect the Inhibition Ability of EGFRL858R/T790M/C797S Inhibitors: A Molecular Dynamics Simulation Study;Molecules;2020-02-18